International: FDA to enhance unannounced inspections of foreign manufacturing facilities in countries including China

International: FDA to enhance unannounced inspections of foreign manufacturing facilities in countries including China

In brief On 6 May 2025, the US Food and Drug Administration (FDA) announced that it will expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for US consumers and patients. The announcement came one day after the White House issued an Executive Order instructing FDA to provide regulatory relief to promote domestic production of critical medicine…